the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Malaysia Airlines flight returns to Paris shortly after departure due to engine indication anomaly

Malaysia Airlines flight MH21 from Paris Charles de Gaulle Airport (CDG) to KL International Airport on Jan 7, 2026

KUALA LUMPUR: Malaysia Airlines confirmed that its flight MH21 operating from Paris Charles de Gaulle Airport (CDG) to KL International Airport on Jan 7 has returned to CDG shortly after departure as a precautionary measure following an engine indication anomaly.

According to Malaysia Aviation Group (MAG), the flight crew requested priority handling and complied with air traffic control instructions, including the use of an emergency transponder code in line with standard aviation safety procedure to facilitate a safe return to CDG for technical inspections.

“The aircraft landed safely at 3:35 pm local time in Paris,” the group said in a statement through Whatsapp today. 

It said affected passengers have been reallocated to alternative carriers where available, while some were accommodated at hotels near the airport.

The replacement flight MH21D is scheduled to depart CDG at 5 pm local time today. 

“Malaysia Airlines deeply regrets the inconvenience and disruptions to our passengers’ travel plans. Safety remains the number one priority to the airline,” it added.

A check in Flightradar24, the scheduled time of departure (STD) for the A350-941 flight was 11.10 am, however, the flight’s actual time of departure (ATD) was at 2.09 pm before the emergency landing happened.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings